Related Experiment Videos
Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix
P Franzén1, H Ichijo, K Miyazono
1Ludwig Institute for Cancer Research, Biomedical Center, Uppsala, Sweden.
Abstract:
The effects of transforming growth factor-beta 1 (TGF-beta 1) on a human prostatic carcinoma cell line PC-3, and its subclone PC-3U, were investigated. Dose-dependent inhibition of [3H]thymidine incorporation in PC-3U cells was observed by addition of TGF-beta 1, although only 50% inhibition was obtained by high concentrations (12 nM) of TGF-beta 1. The growth inhibitory effects of TGF-beta 1 on PC-3 cells was insignificant. When 0.3 ng/ml of phorbol 12-myristate 13-acetate (PMA) was added together with TGF-beta 1, TGF-beta 1 inhibited growth of PC-3 cells (about 50% inhibition), and the growth inhibitory activity of TGF-beta 1 in PC-3U cells was enhanced (more than 90% inhibition). Affinity crosslinking studies revealed that both cell lines possess all of the three described forms of TGF-beta receptors. The intensities of the crosslinked bands were weaker in the PC-3 cells than in PC-3U cells, and those were not increased by the addition of PMA. The expression of the TGF-beta type II receptor mRNA did not change after the addition of PMA or TGF-beta 1. These results suggest that the effects of PMA involved downstream components of the signal transduction pathway of TGF-beta 1. TGF-beta 1 is known to stimulate the production of extracellular matrix proteins and to induce changes in the expression of nuclear transcription factor genes. In both PC-3 and PC-3U cells, TGF-beta 1 was found to stimulate the induction of fibronectin and plasminogen activator inhibitor-1 and the expression of junB mRNA, and PMA did not affect these responses. Thus, PC-3 and PC-3U cells, which are partially resistant to the growth inhibitory activity of TGF-beta 1, could still respond to TGF-beta 1 by extracellular matrix production, independent of PMA action. These results suggest that different signalling pathways mediate TGF-beta 1-induced growth inhibition and stimulation of extracellular matrix accumulation in these cells.
Insights
Transforming growth factor-beta 1 (TGF-beta 1) partially inhibits prostate cancer cell growth and stimulates extracellular matrix production. Phobol 12-myristate 13-acetate (PMA) enhances TGF-beta 1
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor-beta 1 (TGF-beta 1) is a key regulator of cell growth and extracellular matrix production.
- Prostate cancer cell lines PC-3 and PC-3U exhibit differential responses to TGF-beta 1.
- Understanding TGF-beta 1 signaling is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the effects of TGF-beta 1 on human prostatic carcinoma cell lines PC-3 and PC-3U.
- To determine the role of phorbol 12-myristate 13-acetate (PMA) in modulating TGF-beta 1 responses.
- To elucidate the signaling pathways involved in TGF-beta 1-induced growth inhibition and extracellular matrix production.
Main Methods:
- Cell culture of PC-3 and PC-3U human prostate cancer cell lines.
- Measurement of [3H]thymidine incorporation to assess cell proliferation.
- Affinity crosslinking to analyze TGF-beta receptor expression.
- Quantitative analysis of fibronectin, plasminogen activator inhibitor-1, and junB mRNA expression.
Main Results:
- TGF-beta 1 dose-dependently inhibited [3H]thymidine incorporation in PC-3U cells, with partial inhibition in PC-3 cells.
- PMA enhanced TGF-beta 1's growth inhibitory effects on PC-3 cells and augmented its activity in PC-3U cells.
- Both cell lines expressed TGF-beta receptors, but PMA did not alter receptor levels or TGF-beta type II receptor mRNA expression.
- TGF-beta 1 stimulated fibronectin, plasminogen activator inhibitor-1, and junB mRNA expression independently of PMA.
- These responses suggest distinct signaling pathways mediate TGF-beta 1's effects on growth inhibition versus extracellular matrix production.
Conclusions:
- Prostate cancer cells PC-3 and PC-3U display partial resistance to TGF-beta 1-induced growth inhibition.
- TGF-beta 1 can stimulate extracellular matrix production in these cells, irrespective of PMA.
- Distinct signaling pathways mediate TGF-beta 1's opposing effects on cell growth and matrix accumulation.
- These findings offer insights into TGF-beta 1's complex role in prostate cancer progression and potential therapeutic strategies.